PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
BMC Cancer10.1186/1471-2407-11-3702011111Factors determining the survival of nasopharyngeal carcinoma with lung metastasis alone: does combined modality treatment benefit?Xun Cao, Li-Ru He, Fang-Yun Xie, You-Fang Chen, Zhe-Sheng Wenhttp://link.springer.com/content/pdf/10.1186/1471-2407-11-370.pdf, http://link.springer.com/article/10.1186/1471-2407-11-370/fulltext.html, http://link.springer.com/content/pdf/10.1186/1471-2407-11-370, https://link.springer.com/content/pdf/10.1186/1471-2407-11-370.pdf
Molecular Therapy10.1016/s1525-0016(16)43222-3200255S129-S130392. p16 Cancer Gene Therapy: An Efficacious Modality in the Treatment of Nasopharyngeal Carcinoma (NPC)https://api.elsevier.com/content/article/PII:S1525001616432223?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1525001616432223?httpAccept=text/plain
Cancer10.1002/cncr.2168320061064820-829Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinomaWilliam C. Chen, Andrew Jackson, Amy S. Budnick, David G. Pfister, Dennis H. Kraus, Margie A. Hunt, Hilda Stambuk, Sabine Levegrun, Suzanne L. Woldenhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncr.21683, https://onlinelibrary.wiley.com/doi/full/10.1002/cncr.21683
International Journal of Radiation Oncology*Biology*Physics10.1016/j.ijrobp.2005.07.219200563S128-S129Sensorineural Hearing Loss in Combined Modality Treatment of Nasopharyngeal CarcinomaW.C. Chen, A. Jackson, A.S. Budnick, D.G. Pfister, D.H. Kraus, M.A. Hunt, S.L. Woldenhttps://api.elsevier.com/content/article/PII:S0360301605014082?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0360301605014082?httpAccept=text/plain
Lung Cancer10.1016/s0169-5002(86)80594-3198621-2161Combined modality treatment of small-cell bronchial carcinomahttps://api.elsevier.com/content/article/PII:S0169500286805943?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500286805943?httpAccept=text/plain
Lung Cancer10.1016/0169-5002(90)90381-u199061-263Combined modality treatment of small-cell bronchial carcinoma: Aspects of chemotherapy and internal treatmenthttps://api.elsevier.com/content/article/PII:016950029090381U?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:016950029090381U?httpAccept=text/plain
Clinical Oncology10.1016/s0936-6555(98)80028-91998106354-355Combined modality treatment in oesophageal carcinomaT.S. Maughan, T.D.L. Crosbyhttps://api.elsevier.com/content/article/PII:S0936655598800289?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0936655598800289?httpAccept=text/plain
Atlas of Clinical Urology10.1007/978-1-4613-1101-0_6200071-85Combined-modality Treatment of Renal Cell CarcinomaRonald M. Bukowskihttp://link.springer.com/content/pdf/10.1007/978-1-4613-1101-0_6
Current Treatment Options in Oncology10.1007/s11864-004-0041-320045285-95Carcinoma of the vulva: Combined modality treatmentGustavo S. Montanahttp://link.springer.com/content/pdf/10.1007/s11864-004-0041-3.pdf, http://link.springer.com/article/10.1007/s11864-004-0041-3/fulltext.html, http://link.springer.com/content/pdf/10.1007/s11864-004-0041-3
Yearbook of Dentistry10.1016/s0084-3717(08)70137-520062006163-164Role of Combined Modality Treatment of Buccal Mucosa Squamous Cell CarcinomaJ.M. Hendersonhttps://api.elsevier.com/content/article/PII:S0084371708701375?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0084371708701375?httpAccept=text/plain